Intended for healthcare professionals

  1. Research
  2. Relation between...
  3. Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study
Primary Care

Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7386.426 (Published 22 February 2003) Cite this as: BMJ 2003;326:426
  1. E Løkkegaard, research fellow (loekkegaard{at}dadlnet.dk),
  2. A T Pedersen, senior registrara,
  3. B L Heitmann, professore,
  4. Z Jovanovic, statisticianc,
  5. N Keiding, professorc,
  6. Y A Hundrup, master of nursingd,
  7. E B Obel, consultantd,
  8. B Ottesen, professorb
  1. a Department of Obstetrics and Gynaecology, Hvidovre University Hospital, Kettegård alle 30, DK-2650 Hvidovre, Denmark
  2. b Juliane Marie Centre, H:s Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark
  3. c Department of Biostatistics, Panûm Instituttet, University of Copenhagen
  4. d Danish Nurse Study, National Institute of Public Health, DK-2100 Copenhagen, Denmark
  5. e Research Unit for Dietary Studies, Institute of Preventive Medicine, Copenhagen University Hospital, DK-1399 Copenhagen, Denmark
  1. Correspondence to: E Løkkegaard
  • Accepted 31 December 2002

Abstract

Objective: To investigate the risk of ischaemic heart disease and myocardial infarction among women using hormone replacement therapy, especially the potential modifying effect of cardiovascular risk factors.

Design: Prospective observational study.

Setting: Denmark.

Participants: 19 898 nurses aged 45 and over completing a questionnaire on lifestyle and use of hormone replacement therapy in 1993.

Main outcome measures: All cases of death and incident cases of ischaemic heart disease and myocardial infarction until the end of 1998.

Results: Current users of hormone replacement therapy smoked more, consumed more alcohol, had lower self rated health, but were slimmer and had a lower prevalence of diabetes than never users. In current users compared with never users, hormone replacement therapy had no protective effect on ischaemic heart disease (hazard ratio 1.2, 0.9 to 1.7) or myocardial infarction (1.0, 0.6 to 1.7), whereas current users with diabetes had an increased risk of death (3.2, 1.4 to 7.5), ischaemic heart disease (4.2, 1.4 to 12.5), and myocardial infarction (9.2, 2.0 to 41.4) compared with never users with diabetes.

Conclusion: Hormone replacement therapy showed no protective effect on ischaemic heart disease, but there was a significantly increased risk of death from all causes and ischaemic heart disease among women with diabetes.

What is already known on this topic

What is already known on this topic Observational studies have shown that hormone replacement therapy protects women against ischaemic heart disease

Randomised clinical trials found no such effect

Little attention has focused on identifying subgroups of women who would or would not benefit from treatment

What this study adds

What this study adds Hormone replacement therapy does not protect against ischaemic heart disease

Women with diabetes who use hormone replacement therapy are at an increased risk of death from all causes and ischaemic heart disease

Footnotes

  • Funding Danish Heart Association and Hvidovre Hospital.

  • Competing interests BO and ATP have been reimbursed by pharmaceutical companies with an interest in hormone replacement therapy for attending and speaking at several conferences. BO has also received funding for laboratory research. EL received a grant sponsored by Organon.

  • Ethical approval The study was approved by the scientific and ethical committees for Copenhagen and Frederiksberg (J.rt (KF) 01-103/93), the Danish Data Protection Agency was notified (1990-1110-270), and the Danish National Board of Health gave permission for access to the National Registry of Hospital Discharges and Death.

  • Accepted 31 December 2002
View Full Text
Back to top